"sample_molecule_ch1","sample_molecule_ch2","sample_source_name_ch1","sample_status","sample_library_selection","sample_library_source","sample_extract_protocol_ch1","sample_extract_protocol_ch2","sample_label_protocol_ch1","sample_source_name_ch2","sample_library_strategy","sample_characteristics_ch2","sample_label_protocol_ch2","sample_label_protocol","sample_series_id","sample_data_processing","sample_description","sample_characteristics_ch1","sample_organism_ch1","tissue","sample_type","sample_title","sample_name","sample_hyb_protocol","sample_label_ch2","disease_state","ethnicity","time_point","tmprss2","treatment","cancer_status","tissuer_type","tumor_type","age","gleason_score","pathologic_tumor_stage","gleason_grade","t-stage","margin_status","preop_psa","bcr","bcr_free_time"
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT1; 3148)  treated with DMSO","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DMSO_PAT1","pcaf_dmso_pat1",NA,NA,NA,NA,NA,NA,"DMSO",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT2; 1341)  treated with DMSO","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DMSO_PAT2","pcaf_dmso_pat2",NA,NA,NA,NA,NA,NA,"DMSO",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT3; 5201)  treated with DMSO","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DMSO_PAT3","pcaf_dmso_pat3",NA,NA,NA,NA,NA,NA,"DMSO",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT4; 1869)  treated with DMSO","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DMSO_PAT4","pcaf_dmso_pat4",NA,NA,NA,NA,NA,NA,"DMSO",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT1; 3148)  treated with Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DEX_PAT1","pcaf_dex_pat1",NA,NA,NA,NA,NA,NA,"Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT2; 1341)  treated with Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DEX_PAT2","pcaf_dex_pat2",NA,NA,NA,NA,NA,NA,"Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT3; 5201)  treated with Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DEX_PAT3","pcaf_dex_pat3",NA,NA,NA,NA,NA,NA,"Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT4; 1869)  treated with Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_DEX_PAT4","pcaf_dex_pat4",NA,NA,NA,NA,NA,NA,"Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT1; 3148)  treated with RU486+Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_RU486_DEX_PAT1","pcaf_ru486_dex_pat1",NA,NA,NA,NA,NA,NA,"RU486+Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT2; 1341)  treated with RU486+Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_RU486_DEX_PAT2","pcaf_ru486_dex_pat2",NA,NA,NA,NA,NA,NA,"RU486+Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT3; 5201)  treated with RU486+Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_RU486_DEX_PAT3","pcaf_ru486_dex_pat3",NA,NA,NA,NA,NA,NA,"RU486+Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA",NA,"Primary human prostate cancer associated fibroblasts (PAT4; 1869)  treated with RU486+Dex","Public on Aug 10 2024",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSE240480",NA,"gene expression profiling of treated primary CAFs",NA,"Homo sapiens",NA,"RNA","PCAF_RU486_DEX_PAT4","pcaf_ru486_dex_pat4",NA,NA,NA,NA,NA,NA,"RU486+Dexamethasone",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
